Hologic Inc
HOLX: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$66.00 | Ndrwzf | Jydqcbdj |
Hologic Seeks to Navigate COVID-19 Declines While Ramping Up Demand for New Tests
Business Strategy and Outlook
Under CEO Stephen MacMillan's watch, Hologic has been able to focus on structural competitive advantages, improve its balance sheet, and judiciously step into complementary markets, which has smoothed out the vagaries of product cycles.